Mackay Shields LLC Neogenomics Inc Transaction History

Mackay Shields LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $230,912 - $361,408	-6,400 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$33.26 - $40.48 $212,864 - $259,071	6,400 New	6,400 $237,000
Q2 2020 Jul 31, 2020	SELL	$24.21 - $31.02 $881,244 - $1.13 Million	-36,400 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$20.5 - $34.53 $746,200 - $1.26 Million	36,400 New	36,400 $1.01 Million
Q3 2019 Nov 01, 2019	SELL	$19.12 - $26.24 $3.68 Million - $5.05 Million	-192,383 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $2.03 Million - $2.5 Million	103,783 Added 117.14%	192,383 $4.22 Million
Q1 2019 May 13, 2019	BUY	$12.14 - $20.46 $525,662 - $885,918	43,300 Added 95.58%	88,600 $1.81 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $509,172 - $838,050	45,300 New	45,300 $571,000

296

125M

698K

116K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.7B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.